Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Novel alanine serine cysteine transporter 2 (ASCT2) inhibitors based on sulfonamide and sulfonic acid ester scaffolds.

Ndaru E, Garibsingh RA, Shi Y, Wallace E, Zakrepine P, Wang J, Schlessinger A, Grewer C.

J Gen Physiol. 2019 Feb 4. pii: jgp.201812276. doi: 10.1085/jgp.201812276. [Epub ahead of print]

PMID:
30718375
2.

Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2.

Garibsingh RA, Otte NJ, Ndaru E, Colas C, Grewer C, Holst J, Schlessinger A.

Front Chem. 2018 Jul 24;6:279. doi: 10.3389/fchem.2018.00279. eCollection 2018.

3.

Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations.

Troilo A, Benson EK, Esposito D, Garibsingh RA, Reddy EP, Mungamuri SK, Aaronson SA.

Oncotarget. 2016 May 17;7(20):28765-82. doi: 10.18632/oncotarget.9117.

Supplemental Content

Loading ...
Support Center